Ulf Grawunder
Directeur/Membre du Conseil chez WUXI XDC CAYMAN INC.
Profil
Ulf Grawunder was the founder of 4-Antibody AG, founded in 2002, where he held the title of Chief Scientist from 2009 to 2010.
He is also the founder of NBE-Therapeutics AG, founded in 2012, where he currently holds the title of Director, Chief Operating & Development Officer.
Additionally, Dr. Grawunder is the founder of T-CURX GmbH, founded in 2022, where he currently serves as the Chief Executive Officer.
Dr. Grawunder's current job(s) include being an Independent Non-Executive Director at WuXi XDC Cayman, Inc., an Independent Director at Adagene, Inc., and the Managing Partner at Viopas Venture Consulting GmbH.
Dr. Grawunder's former job includes being a Principal at the University of Southern California.
In terms of education, Dr. Grawunder obtained a doctorate degree from the University of Basel in 1994 and a graduate degree from the University of Bayreuth in 1991.
Postes actifs de Ulf Grawunder
| Sociétés | Poste | Début |
|---|---|---|
| WUXI XDC CAYMAN INC. | Directeur/Membre du Conseil | - |
| ADAGENE INC. | Directeur/Membre du Conseil | 01/04/2024 |
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Fondateur | 18/04/2012 |
| T-CURX GmbH | Directeur Général | 01/09/2022 |
Viopas Venture Consulting GmbH
 Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Corporate Officer/Principal | 01/01/2022 |
Anciens postes connus de Ulf Grawunder
| Sociétés | Poste | Fin |
|---|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Fondateur | - |
Formation de Ulf Grawunder
| University of Basel | Doctorate Degree |
| University of Bayreuth | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| WUXI XDC CAYMAN INC. | Commercial Services |
| ADAGENE INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Health Technology |
| T-CURX GmbH | |
Viopas Venture Consulting GmbH
Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Finance |
